BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7699112)

  • 21. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
    Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
    Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brainstem projections to midline and intralaminar thalamic nuclei of the rat.
    Krout KE; Belzer RE; Loewy AD
    J Comp Neurol; 2002 Jun; 448(1):53-101. PubMed ID: 12012375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Projections of GABAergic and cholinergic basal forebrain and GABAergic preoptic-anterior hypothalamic neurons to the posterior lateral hypothalamus of the rat.
    Gritti I; Mainville L; Jones BE
    J Comp Neurol; 1994 Jan; 339(2):251-68. PubMed ID: 8300907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rabbit forebrain cholinergic system: morphological characterization of nuclei and distribution of cholinergic terminals in the cerebral cortex and hippocampus.
    Varga C; Härtig W; Grosche J; Keijser J; Luiten PG; Seeger J; Brauer K; Harkany T
    J Comp Neurol; 2003 Jun; 460(4):597-611. PubMed ID: 12717717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease.
    Pearson RC; Powell TP
    J Neural Transm Suppl; 1987; 24():139-46. PubMed ID: 3119773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases.
    De Bruin VM; Lees AJ
    Mov Disord; 1994 Jul; 9(4):381-9. PubMed ID: 7969203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes within the basal nucleus in Parkinson's disease.
    Ulfig N; Braak E; Braak H
    Prog Clin Biol Res; 1989; 317():493-500. PubMed ID: 2690110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.
    Arendt T; Bigl V; Arendt A; Tennstedt A
    Acta Neuropathol; 1983; 61(2):101-8. PubMed ID: 6637393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Organic correlates of depressive symptoms in Alzheimer's dementia. Results of a prospective study, review of the literature].
    Förstl H; Burns A; Cairns N; Luthert P; Lantos P; Levy R
    Nervenarzt; 1992 Sep; 63(9):566-74. PubMed ID: 1407228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Origin of the neurotensinergic innervation of the rat basal forebrain studied by retrograde transport of cholera toxin.
    Morin AJ; Beaudet A
    J Comp Neurol; 1998 Feb; 391(1):30-41. PubMed ID: 9527539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurons in the basal forebrain complex of the rat: a Golgi study.
    Brauer K; Schober W; Werner L; Winkelmann E; Lungwitz W; Hajdu F
    J Hirnforsch; 1988; 29(1):43-71. PubMed ID: 3385197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atlas of the serotonin-containing cell bodies and fibers in the central nervous system of the hedgehog.
    Michaloudi EC; Papadopoulos GC
    J Hirnforsch; 1995; 36(1):77-100. PubMed ID: 7751613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
    Rasool CG; Svendsen CN; Selkoe DJ
    Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathological correlates of memory dysfunction in the Wernicke-Korsakoff syndrome.
    Halliday G; Cullen K; Harding A
    Alcohol Alcohol Suppl; 1994; 2():245-51. PubMed ID: 8974343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regeneration of serotonergic immunoreactive fibers in the brain of 5,6-dihydroxytryptamine treated rat.
    Ueda S; Kawata M
    J Hirnforsch; 1994; 35(1):159-80. PubMed ID: 8021452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Alzheimer disease-related calcium-binding protein Calmyrin is present in human forebrain with an altered distribution in Alzheimer's as compared to normal ageing brains.
    Bernstein HG; Blazejczyk M; Rudka T; Gundelfinger ED; Dobrowolny H; Bogerts B; Kreutz MR; Kuznicki J; Wojda U
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):314-24. PubMed ID: 15885068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pedunculopontine nucleus in Parkinson's disease.
    Zweig RM; Jankel WR; Hedreen JC; Mayeux R; Price DL
    Ann Neurol; 1989 Jul; 26(1):41-6. PubMed ID: 2549845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuropathology of aminergic nuclei in Alzheimer's disease.
    Zweig RM; Ross CA; Hedreen JC; Steele C; Cardillo JE; Whitehouse PJ; Folstein MF; Price DL
    Ann Neurol; 1988 Aug; 24(2):233-42. PubMed ID: 3178178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep research in space: expression of immediate early genes in forebrain structures of rats during the nasa neurolab mission (STS-90).
    Centini C; Pompeiano O
    Arch Ital Biol; 2007 May; 145(2):117-50. PubMed ID: 17639784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.